Skip to main content

Advertisement

Log in

Bioluminescence and chemiluminescence in drug screening

  • Special Issue Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Drug screening, that is, the evaluation of the biological activity of candidate drug molecules, is a key step in the drug discovery and development process. In recent years, high-throughput screening assays have become indispensable for early stage drug discovery because of the developments in synthesis technologies, such as combinatorial chemistry and automated synthesis, and the discovery of an increasing number of new pharmacological targets.

Bioluminescence and chemiluminescence represent suitable detection techniques for high-throughput screening because they allow rapid and sensitive detection of the analytes and can be applied to small-volume samples. In this paper we report on recent applications of bioluminescence and chemiluminescence in drug screening, both for in vitro and in vivo assays. Particular attention is devoted to the latest and most innovative bioluminescence and chemiluminescence-based technologies for drug screening, such as assays based on genetically modified cells, bioluminescence resonance energy transfer (BRET)-based assays, and in vivo imaging assays using transgenic animals or bioluminescent markers. The possible relevance of bioluminescence and chemiluminescence techniques in the future developments of high-throughput screening technologies is also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. Garcia-Campana AM, Baeyens WRG (2001) (eds) Chemiluminescence in analytical chemistry. Marcel Dekker, New York

  2. Van Dyke K, Van Dyke C, Woodfork K (2002) (eds) Luminescence biotechnology: instruments and applications. CRC Press, Boca Raton

  3. Campbell AK (1988) Chemiluminescence: principles and applications in biology and medicine. VCH, Cambridge, chap 5

  4. Lehel C, Daniel-Issakani S, Brasseur M, Strulovici B (1997) Anal Biochem 244:340–346

    Article  CAS  PubMed  Google Scholar 

  5. Ross H, Armstrong CG, Cohen P (2002) Biochem J 366:977–981

    CAS  PubMed  Google Scholar 

  6. Maurer TS, Fung H (2000) Nitric Oxide 4:372–278

    Article  CAS  PubMed  Google Scholar 

  7. Andreani A, Cavalli A, Granaiola M, Guardigli M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Recanatini M, Roda A (2001) J Med Chem 44:4011–4014

    Article  CAS  PubMed  Google Scholar 

  8. Forghani F, Ouellet M, Keen S, Percival MD (1998) Anal Biochem 264:216–221

    Article  CAS  PubMed  Google Scholar 

  9. Roda A, Russo C, Pasini P, Piazza F, Feroci G, Kricka LJ, Baraldini M (1998) J Biolumin Chemilumin 13:327–337

    Article  CAS  PubMed  Google Scholar 

  10. Deo SK, Lewis JC, Daunert S (2000) Anal Biochem 281:87–94

    Article  CAS  PubMed  Google Scholar 

  11. Mirasoli M, Pasini P, Russo C, Lotierzo M, Valenti P, Guardigli M, Roda A. In Roda A, Pazzagli M, Kricka LJ, Stanley PE (1999) (eds) Bioluminescence and chemiluminescence: perspectives for the 21st century. Wiley, Chichester, pp 524–527

  12. Ogawa A, Arai H, Tanaziwa H, Miyahara T, Toyo'oka T (1999) Anal Chim Acta 383:221–230

    Article  CAS  Google Scholar 

  13. Salles B, Sattler U, Bozzato C, Calsou P (1999) Food Chem Toxicol 37:1009–1014

    Article  CAS  PubMed  Google Scholar 

  14. Joyeux A, Balaguer P, Germain P, Boussioux AM, Pons M, Nicolas JC (1997) Anal Biochem 249:119–130

    Article  CAS  PubMed  Google Scholar 

  15. Naylor LH (1999) Biochem Pharmacol 58:749–757

    CAS  PubMed  Google Scholar 

  16. Deo SK, Daunert S (2001) Fresenius J Anal Chem 369:258–266

    CAS  PubMed  Google Scholar 

  17. Terouanne B, Tahiri B, Georget V, Belon C, Poujol N, Avances C, Orio F Jr, Balaguer P, Sultan C (2000) Mol Cell Endocrinol 160:39–49

    Article  CAS  PubMed  Google Scholar 

  18. Blankvoort BM, de Groene EM, van Meeteren-Kreikamp AP, Witkamp RF, Rodenburg RJ, Aarts JM (2001) Anal Biochem 298:93–102

    Article  CAS  PubMed  Google Scholar 

  19. Beckers T, Reilander H, Hilgard P (1997) Anal Biochem 251:17–23

    Article  CAS  PubMed  Google Scholar 

  20. Conway S, Canning SJ, Howell HE, Mowat ES, Barrett P, Drew JE, Delagrange P, Lesieur D, Morgan PJ (2000) Eur J Pharmacol 390:15–24

    Article  CAS  PubMed  Google Scholar 

  21. Terstappen GC, Giacometti A, Ballini E, Aldegheri L (2000) J Biomol Screen 5:255–262

    Article  CAS  PubMed  Google Scholar 

  22. Goetz AS, Andrews JL, Littleton TR, Ignar DM (2000) J Biomol Screen 5:377–84

    CAS  PubMed  Google Scholar 

  23. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B (1999) Science 284:1362–5

    Article  CAS  PubMed  Google Scholar 

  24. Repa JJ, Mangelsdorf DJ (2000) Annu Rev Cell Dev Biol 16:459–81

    CAS  PubMed  Google Scholar 

  25. Postlind H, Vu TP, Tukey RH, Quattrochi LC (1993) Toxicol Appl Pharmacol 118:255–262

    Article  CAS  PubMed  Google Scholar 

  26. Boute N, Pernet K, Issad T (2001) Mol Pharmacol 60:640–645

    CAS  PubMed  Google Scholar 

  27. Issad T, Boute N, Pernet K (2002) Biochem Pharmacol 64:813–817

    Article  CAS  PubMed  Google Scholar 

  28. Rios CD, Jordan BA, Gomes I, Devi LA (2001) Pharmacol Ther 92:71–87

    Article  CAS  PubMed  Google Scholar 

  29. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M (2000) Proc Natl Acad Sci USA 97:3684–9

    Article  CAS  PubMed  Google Scholar 

  30. Boute N, Jockers R, Issad T (2002) Trends Pharmacol Sci 23:351–354

    Article  CAS  PubMed  Google Scholar 

  31. Contag PR (2002) Drug Discov Today 7:555–562

    Article  CAS  PubMed  Google Scholar 

  32. Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, Contag PR (2000) Infect Immun 68:3594–3600

    Article  CAS  PubMed  Google Scholar 

  33. Sweeney TJ, Mailänder V, Tucker AA, Olomu AB, Zhang W, Cao Y, Negrin RS, Contag CH (1999) PNAS 96:12044–12049

    Article  CAS  PubMed  Google Scholar 

  34. Contag CH, Jenkins D, Contag PR, Negrin RS (2000) Neoplasia 2:41–52

    CAS  PubMed  Google Scholar 

  35. Laxman B, Hall DE, Swaroop Bhojani M, Hamstra DA, Chenevert TL, Ross BD, Rehemtulla A (2002) PNAS 99:16551–16555

    Article  CAS  PubMed  Google Scholar 

  36. Paulmurugan R, Umezawa Y, Gambhir SS (2002) PNAS 99:15608–15613

    Article  CAS  PubMed  Google Scholar 

  37. O'Connell-Rodwell CE, Burns SM, Bachmann MH, Contag CH (2002) Trends Biotechnol 20:S19-S23

    Article  PubMed  Google Scholar 

  38. Contag CH, Contag PR (1999) Chem Ind 6:664–666

    Google Scholar 

  39. Rocchetta HL, Boylan CJ, Foley JW, Iversen PW, LeTourneau DL, McMillian CL, Contag PR, Jenkins DE, Parr TR Jr (2001) Antimicrob Agents Chemother 45:129–137

    Article  CAS  PubMed  Google Scholar 

  40. Templin MF, Stoll D, Schrenk M, Traub PC, Vöhringer CF, Thomas OJ (2002) Trends Biotechnol 20:160–166

    CAS  PubMed  Google Scholar 

  41. MacBeath G, Koehler AN, Schreiber SL (1999) J Am Chem Soc 121:7967–7968

    Article  CAS  Google Scholar 

  42. Weigl HB, Bardell RL, Cabrera CR (2003) Adv Drug Deliver Rev 55:349–377

    Article  CAS  Google Scholar 

  43. Kanigan T, Brenan C, Lafontaine S, Soswoski L, Madden P, Hunter I (2000) SPIE Proceedings, 3926, pp. 172–180

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aldo Roda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roda, A., Guardigli, M., Pasini, P. et al. Bioluminescence and chemiluminescence in drug screening. Anal Bioanal Chem 377, 826–833 (2003). https://doi.org/10.1007/s00216-003-2096-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-003-2096-6

Keywords

Navigation